EMVision Medical Devices Secures AU$1.2 Million IGP Grant After First Responder Milestone

MT Newswires Live
05/25

EMVision Medical Devices (ASX:EMV) has confirmed that it has met the required progress under its first responder program, triggering the next grant instalment of AU$1.2 million from the Australian Government's industry growth program (IGP), which is expected to be received in May, according to a Monday filing with the Australian bourse.

The funding forms part of a AU$5 million non-dilutive grant awarded in June 2025 to support the commercialization of its first responder brain scanner, a portable device intended for pre-hospital use in emergency road and aeromedical settings, per the filing.

Payments are disbursed quarterly in advance, subject to eligible spending and milestone delivery, with the company having received AU$1 million so far and AU$2.8 million remaining under the grant facility, the filing added.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10